Transfer of F351 Rights Outside China to CBIO and Share Exchange

A transaction involving the transfer of F351 rights outside China to Catalyst Biosciences (CBIO) and the receipt of CBIO shares through an in-kind contribution of Beijing Continent shares. It concerns a restructuring of the business and capital relationship through a rights transfer and share exchange.